Insider Transactions in Q1 2025 at Structure Therapeutics Inc. (GPCR)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2025
|
Raymond C Stevens CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
340,332
+23.09%
|
-
|
|
Mar 15
2025
|
Jun Yoon CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
170,166
+11.63%
|
-
|
|
Mar 15
2025
|
Xichen Lin CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
80,829
+32.68%
|
-
|
|
Mar 15
2025
|
Yingli Ma CHIEF TECHNOLOGY OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
63,810
+38.83%
|
-
|
|
Mar 15
2025
|
Ashley Hall Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
51,048
+30.14%
|
-
|
|
Mar 15
2025
|
Crespo Blas Coll CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
116,988
+34.76%
|
-
|
|
Mar 01
2025
|
Raymond C Stevens CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
12,495
-1.1%
|
$87,465
$7.92 P/Share
|
|
Mar 01
2025
|
Jun Yoon CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
5,940
-0.46%
|
$41,580
$7.92 P/Share
|
|
Mar 01
2025
|
Xichen Lin CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
6,441
-3.87%
|
$45,087
$7.92 P/Share
|
|
Mar 01
2025
|
Yingli Ma CHIEF TECHNOLOGY OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,824
-1.81%
|
$12,768
$7.92 P/Share
|
|
Mar 01
2025
|
Crespo Blas Coll CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,233
-0.56%
|
$8,631
$7.92 P/Share
|